<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04984200</url>
  </required_header>
  <id_info>
    <org_study_id>EN-01b</org_study_id>
    <nct_id>NCT04984200</nct_id>
  </id_info>
  <brief_title>Assessment of EyeArt Performance With Retinal Cameras</brief_title>
  <official_title>Assessment of EyeArt Performance With Retinal Cameras</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eyenuk, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eyenuk, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates the performance of the EyeArt system for detecting diabetic retinopathy&#xD;
      from images captured using retinal cameras and operators.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">July 13, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall agreement between the results from multiple EyeArt operations</measure>
    <time_frame>1 visit (1 day)</time_frame>
    <description>Overall agreement is defined as the fraction of cases where the multiple EyeArt operation results agree with each other.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">168</enrollment>
  <condition>Diabetic Retinopathy</condition>
  <arm_group>
    <arm_group_label>AB</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Retinal imaging</intervention_name>
    <description>Subjects will undergo retinal imaging before and/or after administration of mydriatic agent</description>
    <arm_group_label>AB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mydriatic Agent</intervention_name>
    <description>Subjects will be administered mydriatic medication to dilate their pupils.</description>
    <arm_group_label>AB</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study subjects will be enrolled at primary care and/or eye care centers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A diagnosis of diabetes mellitus;&#xD;
&#xD;
          -  Understanding of study and provision of written informed consent; and&#xD;
&#xD;
          -  22 years of age or older.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Persistent visual impairment in one or both eyes;&#xD;
&#xD;
          -  History of retinal vascular (vein or artery) occlusion;&#xD;
&#xD;
          -  History of ocular injections, laser treatment of the retina, or intraocular surgery&#xD;
             other than cataract surgery without complications;&#xD;
&#xD;
          -  Subject is contraindicated for fundus photography (for example, has light&#xD;
             sensitivity);&#xD;
&#xD;
          -  Subject has contraindications for mydriatic medications or is unwilling or unable to&#xD;
             dilate;&#xD;
&#xD;
          -  Subject is currently enrolled in an interventional study of an investigational device&#xD;
             or drug; or&#xD;
&#xD;
          -  Subject has a condition or is in a situation which in the opinion of the Investigator,&#xD;
             might confound study results, may interfere significantly with the subject's&#xD;
             participation in the study, or may result in ungradable dilated fundus photographs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rocky Mountain Diabetes Center</name>
      <address>
        <city>Idaho Falls</city>
        <state>Idaho</state>
        <zip>83404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 16, 2021</study_first_submitted>
  <study_first_submitted_qc>July 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2021</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mydriatics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

